Related Experiment Video

Updated: Aug 26, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

Expression of seven main Rho family members in gastric carcinoma

Yanglin Pan1, Feng Bi, Na Liu

  • 1Institute of Digestive Disease, Xi'jing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710032, PR China.

Biochemical and Biophysical Research Communications
|February 21, 2004
PubMed

Insights

Rho GTPases, specifically RhoA and Rac1, are significantly upregulated in gastric cancer. Their elevated expression correlates with advanced tumor stage and poor differentiation, suggesting a role in gastric carcinoma progression.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Rho GTPases are implicated in cancer development, but their clinical significance in gastric cancer requires further investigation.
  • Understanding Rho GTPase expression in gastric carcinoma is crucial for identifying potential therapeutic targets.

Purpose of the Study:

  • To investigate the mRNA expression levels of seven Rho family members in gastric carcinoma.
  • To examine the total protein levels and activities of key Rho GTPases (RhoA, Rac1, Cdc42) in gastric cancer cell lines.
  • To correlate Rho GTPase expression with clinical parameters of gastric carcinoma.

Main Methods:

  • Semi-quantitative reverse transcription-PCR was used to analyze mRNA expression in 53 gastric carcinoma tissues and 7 cell lines.
  • Western blotting and activity assays were performed to assess protein levels and GTPase activity.
  • Statistical analysis was employed to correlate expression with clinicopathological features.

Main Results:

  • RhoA and Rac1 mRNA levels were significantly higher in gastric cancer tissues compared to adjacent non-tumorous tissues (p < 0.01).
  • Elevated RhoA expression correlated with advanced TNM stage and poor histological differentiation (p < 0.05).
  • Increased Rac1 expression was associated with higher TNM stages (p < 0.05).
  • RhoA and Rac1 mRNA, protein, and activity were higher in gastric cancer cell lines than in normal gastric epithelial cells.

Conclusions:

  • RhoA and Rac1 play significant roles in the carcinogenesis and progression of gastric carcinoma.
  • Their elevated expression and activity suggest potential as biomarkers and therapeutic targets in gastric cancer.

More Related Videos

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...